These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 31768628

  • 1. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
    Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R.
    J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628
    [Abstract] [Full Text] [Related]

  • 2. Diffusion tensor imaging reveals greater microstructure damage in lesional tissue that shrinks into cerebrospinal fluid in multiple sclerosis.
    Bergsland N, Dwyer MG, Jakimovski D, Weinstock-Guttman B, Zivadinov R.
    J Neuroimaging; 2021 Sep; 31(5):995-1002. PubMed ID: 34081373
    [Abstract] [Full Text] [Related]

  • 3. Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.
    Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R.
    Radiology; 2019 Nov; 293(2):424-433. PubMed ID: 31549947
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
    Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R.
    J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
    [Abstract] [Full Text] [Related]

  • 6. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S.
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [Abstract] [Full Text] [Related]

  • 7. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation.
    Jakimovski D, Qureshi F, Ramanathan M, Jalaleddini K, Ghoreyshi A, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R.
    J Neurol Sci; 2024 Jun 15; 461():123055. PubMed ID: 38761669
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
    Håkansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J.
    J Neuroinflammation; 2018 Jul 18; 15(1):209. PubMed ID: 30021640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis.
    Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Weinstock-Guttman B, Zivadinov R.
    Mult Scler Relat Disord; 2024 Jul 18; 87():105668. PubMed ID: 38744032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
    Håkansson I, Johansson L, Dahle C, Vrethem M, Ernerudh J.
    Mult Scler Relat Disord; 2019 Nov 18; 36():101424. PubMed ID: 31586802
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.